QbD-Steered Development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance-Reference-Cited by-同舟云学术

QbD-Steered Development of Biotin-Conjugated Nanostructured Lipid Carriers for Oral Delivery of Chrysin: Role of Surface Modification for Improving Biopharmaceutical Performance

Published:2021-01 Issue: Volume:197 Page:111429
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Sharma Teenu,Katare O P,Jain Atul,Jain Sanyog,Chaudhari Dasharath,Borges Bonita,Singh Bhupinder

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference68 articles.

1. Breast Cancer;WHO,2018

2. Flavonoids: an overview;Panche;J. Nutr. Sci.,2016

3. Chrysin: Pharmacological and therapeutic properties;Naz;Life Sci.,2019

4. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action;Mani;Phytochemistry,2018

5. Chrysin: A promising anticancer agent its Current trends and future Perspectives;Mehdi;Eur. Exp. Biol.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD-driven development and characterization of superparamagnetic iron oxide nanoparticles (SPIONS) of a bone-targeting peptide for early detection of osteoporosis;International Journal of Pharmaceutics;2024-04

2. Self-Nanoemulsion Intrigues the Gold Phytopharmaceutical Chrysin: In Vitro Assessment and Intrinsic Analgesic Effect;AAPS PharmSciTech;2024-03-05

3. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route;Journal of Nanotechnology;2023-11-06

4. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies;Drug Delivery and Translational Research;2023-09-28

5. Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured lipid carriers;Nanomedicine;2023-08